Taro Pharmaceutical Industries

Historical 13F Holders

Symbol
TARO
CUSIP
M8737E108
All holders as of
Q1 2025
Type
Equity
Class
SHS
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 1 76.0 $3.27 k
2025 Q1 1 76.0 $3.27 k
2024 Q4 3 246 $3.27 k
2024 Q3 6 2.40 k $3.27 k
2024 Q2 16 680 k $29.2 M
2024 Q1 98 4.83 M $205 M
2023 Q4 93 4.92 M $205 M
2023 Q3 86 4.91 M $185 M
2023 Q2 72 4.83 M $186 M
2023 Q1 62 4.15 M $101 M
2022 Q4 63 4.25 M $123 M
2022 Q3 71 4.34 M $130 M
2022 Q2 73 4.32 M $156 M
2022 Q1 72 4.54 M $197 M
2021 Q4 72 4.62 M $231 M
2021 Q3 71 4.61 M $294 M
2021 Q2 80 4.77 M $344 M
2021 Q1 83 4.84 M $357 M
2020 Q4 87 5.51 M $404 M
2020 Q3 81 4.79 M $262 M
2020 Q2 90 4.80 M $319 M
2020 Q1 97 4.77 M $292 M
2019 Q4 97 4.41 M $386 M
2019 Q3 104 4.25 M $321 M
2019 Q2 110 4.22 M $360 M
2019 Q1 108 4.11 M $444 M
2018 Q4 99 4.20 M $353 M
2018 Q3 121 4.63 M $454 M
2018 Q2 116 4.45 M $512 M
2018 Q1 113 4.54 M $444 M
2017 Q4 131 5.24 M $541 M
2017 Q3 136 5.62 M $633 M
2017 Q2 142 5.98 M $671 M
2017 Q1 143 6.94 M $815 M
2016 Q4 154 6.99 M $735 M
2016 Q3 166 7.48 M $828 M
2016 Q2 168 6.99 M $1.02 B
2016 Q1 173 5.75 M $822 M
2015 Q4 163 5.99 M $926 M
2015 Q3 127 5.11 M $703 M
2015 Q2 111 4.78 M $687 M
2015 Q1 103 5.04 M $711 M
2014 Q4 94 5.33 M $791 M
2014 Q3 86 4.56 M $701 M
2014 Q2 75 4.74 M $665 M
2014 Q1 65 4.04 M $449 M